Sfoglia per RIVISTA
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
Collezione AO Ordine Mauriziano

  

Items : 16

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
AO Ordine Mauriziano
ASL Asti
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Audisio A; Brusa F; Ungaro A; Audisio M; Samuelly A; Turco F; Di Stefano RF; Tucci M; Delcuratolo MD;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;

Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103649. doi: 10.1016/j.critrevonc.2022.103649. Epub 2022 Mar 5.

2022
AO Ordine Mauriziano

Formisano L; Bianco R; Di Maio M; De Placido P; De Placido S; Santaniello A; Napolitano F; Marandino L; Iuliano R; Salomone F; Di Costanzo F; Servetto A;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;

Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Nov;167:103271. doi: 10.1016/j.critrevonc.2021.103271. Epub 2021 Feb 26

2021
AO Ordine Mauriziano

Di Maio M; Loupakis F; Giusti R;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;

Second medical opinion in oncological setting. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3.

2021
AO Ordine Mauriziano

Gori S; Marchetti P; Scagnoli S; Maruzzo M; La Verde N; Russo A; Nicolis F; Cinieri S; Comandone A; Bordonaro R; Beretta G; Lanzetta G; Perrone F; Galvano A; Zagonel V; Di Maio M; Gonzato O;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;

Corrigendum to ""Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer" [Crit. Rev. Oncol. Hematol. 133 (January) (2019) 17-24]. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102867. doi: 10.1016/j.critrevonc.2020.102867. Epub 2020 Feb 12

2020
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Alessandria

Aglietta M; Leone F; De Paolis P; Campra D; Silvestri S; Marino D; Santarelli M; Lombardi P;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.

2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Sperone P; La Salvia A; Muratori L;

"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jan;133:17-24. doi: 10.1016/j.critrevonc.2018.10.009. Epub 2018 Nov 2.

2019
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Alessandria

Aglietta M; Leone F; De Paolis P; Santarelli M; Campra D; Silvestri S; Marino D; Lombardi P;

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:54-66. doi: 10.1016/j.critrevonc.2018.06.011. Epub 2018 Jun 21.

2018
AO Ordine Mauriziano

Trestini I; Carbognin L; Monteverdi S; Zanelli S; De Toma A; Bonaiuto C; Nortilli R; Fiorio E; Pilotto S; Di Maio M; Gasbarrini A; Scambia G; Tortora G; Bria E;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.

2018
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Quality assurance of 3D-CRT: Indications and difficulties in their applications in Critical Reviews in Oncology/Hematology

2009
AO Ordine Mauriziano

Begnozzi L; Benassi M; Bertanelli M; Bonini A; Cionini L; Conte L; Fiorino C; Gabriele P; Gardani G; Giani A; Magri S; Morelli M; Morrica B; Olmi P; Orecchia R; Penduzzu G; Raffaele L; Rosi A; Tabocchini MA; Valdagni R; Viti V;